gms | German Medical Science

27. Deutscher Krebskongress

Deutsche Krebsgesellschaft e. V.

22. - 26.03.2006, Berlin

Combination Analysis of Activator Protein-1 Family Members, Sp1and an Activator Protein-2α-Related Factor Binding to Different Regions of the Urokinase Receptor (u-PAR) Gene in Resected Colorectal Cancers

Meeting Abstract

  • corresponding author presenting/speaker Denis Schewe - Dr. von Haunersches Kinderspital, Ludwig-Maximilians-Universität, München, Deutschland
  • Tobias Biller - Abteilung für experimentelle Chirurgie und Molekulare Onkologie, Universitätsklinikum Mannheim
  • Gabriele Maurer - Chirurgische Klinik Grosshadern, Ludwig-Maximilians-Universität, München
  • Irfan Assangani - Abteilung für experimentelle Chirurgie und Molekulare Onkologie, Universitätsklinikum Mannheim
  • Joerg Leupold - Abteilung für experimentelle Chirurgie und Molekulare Onkologie, Universitätsklinikum Mannheim
  • Ernst Lengyel - Department of Obstetrics and Gynecology, University of Chicago, USA
  • Stefan Post - Abteilung für Chirurgie, Universitätsklinikum Mannheim
  • Heike Allgayer - Abteilung für experimentelle Chirurgie und Molekulare Onkologie, Universitätsklinikum Mannheim

27. Deutscher Krebskongress. Berlin, 22.-26.03.2006. Düsseldorf, Köln: German Medical Science; 2006. DocOP169

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/dkk2006/06dkk279.shtml

Veröffentlicht: 20. März 2006

© 2006 Schewe et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Purpose: Studies on the transactivation of genes via promoter elements have mostly been done on cell lines rather than resected tissues. This, however, is essential to address an in vivo or clinical relevance. We have previously shown tumor-specific binding of Sp1and an activator protein (AP)-2α related factor to promoter region -152/-135 of the metastasis-related u-PAR gene in 60% of in vivo resected cancer tissues. Cell lines have implicated an additional role, and potential synergism, of an AP-1 region (-190/-171) in u-PAR regulation. This study was done to (a) analyze AP-1 binding to this region in resected tumor and normal tissues, and define subgroups in which it is tumor-specific, and (b) to analyze transcription factor binding patterns to both promoter motifs in resected tissues, supporting synergism, and draw first prognostic conclusions.

Experimental Design: In 103 patients with colorectal cancer, electrophoretic mobility shift assay/supershift analysis for u-PAR promoter region -190/-171 was done in tumors and normal tissues. In 71 patients, region -152/-135 was also analyzed. U-PAR protein was measured by ELISA.

Results: Tumor-specific AP-1 binding to region -190/-171 of the u-PAR promoter was found in 40% of patients. Subgroup analysis showed tumor-specific binding for c-Fos in 58%, for c-Jun in 50%, for JunD in 39%, and for Fra-1 in 4% of cases. AP-1 binding correlated significantly with u-PAR protein amounts in both normal and tumor tissues (p < 0.001), in contrast to a tumor-specific correlation with u-PAR of the AP-2/Sp1 region. In analyses for both promoter regions, 62% of cancers showed simultaneous binding for AP-1, AP-2, and Sp1, 11% for AP-1 and AP-2, 16% for AP-2 and Sp1, 4% for AP-2 only, 3% for AP-1 only, and 0% for Sp1 only. The binding of AP-1, AP-2, and Sp1 correlated significantly with each other (p < 0.001), the combination of AP-1 and AP-2 showing the highest correlation with u-PAR (p = 0.008). Preliminary survival analysis indicated a trend for poorer prognosis for binding of all three transcription factors.

Conclusion: This is the first study differentiating transcription factor binding to two important u-PAR promoter regions in a large series of resected tumors and normal tissues. The AP-1 site seems to be a less tumor-specific regulator than the Sp1/AP-2 motif. Nevertheless, data corroborate the hypothesis of synergism between both elements in resected tumors.